Type 2 Diabetes Headlines

TYPE 2 DIABETES HEADLINES

Once-Daily Semaglutide Promising for Treating Severe Nonalcoholic Fatty Liver Disease

Metabolic Syndrome Among Patients With Type 2 Diabetes Associated With High Mean Platelet Volume

Dapagliflozin Significantly Impacts Urine Metabolome in Individuals With T2D

Peripheral Artery Disease May Determine T2D Patients Needing Amputation

Patients With Diabetic Ketoacidosis Have Unique Diagnostic Renal Parameters That May Suggest Disease Severity

Risk of T2D Increases in Acute Coronary Syndrome Patients When Lipoprotein(a) Levels Fall

Lifestyle Changes May Up CVD Risk in Some T2DM Patients

Type 2 Diabetes Tied to Higher Risk for Parkinson Disease

Imeglimin Monotherapy Associated With Substantial Glycemic Improvements Vs Placebo

Short Periods of Intense Physical Activity Associated With Cardiorespiratory Fitness—Especially in Men With Type 2 Diabetes